Q1 2016 Holdings
Filed 2016-05-16 | 134 holdings | $2.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $821.0M | 14,373,538 | 38.7% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $677.0M | 24,213,838 | 31.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $396.4M | 4,806,483 | 18.7% |
| Cerus Corporation(CERS) | COM | 157085101 | $80.4M | 13,553,275 | 3.8% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $56.1M | 1,912,680 | 2.6% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $42.5M | 15,010,534 | 2.0% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $12.5M | 307,915 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $9.4M | 505,521 | 0.4% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $6.4M | 5,498,459 | 0.3% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM NEW | 04280A100 | $4.9M | 1,009,509 | 0.2% |
| Aurinia Pharmaceuticals Inc.(AUPH) | COM | 05156V102 | $2.1M | 711,499 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $1.7M | 23,498,460 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.5M | 43,235,267 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.4M | 50,000 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $910.9K | 6,542,599 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $813.0K | 100,000 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $746.0K | 180,582 | 0.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $712.0K | 11,340 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $595.0K | 142,000 | 0.0% |
| Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | $432.2K | $274,500,000 | 0.0% |
| Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | $397.9K | $259,000,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $338.4K | 13,659,832 | 0.0% |
| Anacor Pharmaceuticals, Inc. | COM | 032420101 | $273.8K | 5,122,375 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $179.3K | 5,509,560 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $96.8K | 3,661,082 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | $89.8K | $22,379,000 | 0.0% |
| Clovis Oncology Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | $87.8K | $129,300,000 | 0.0% |
| Gilead Sciences, Inc. 1.625% 5/1/16 | NOTE 1.625% 5/1/2016 | 375558AP8 | $85.9K | $20,944,000 | 0.0% |
| Anacor Pharmaceuticals Inc. 2.0% 15 OCT 2021 | NOTE 2.0% 10/15/2021 | 032420AC5 | $75.3K | $42,000,000 | 0.0% |
| Xenoport, Inc. Notes 2.5% 2/1/2022 | NOTE 2.5% 2/1/2022 | 98411CAB6 | $73.4K | $100,000,000 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $69.9K | 3,268,556 | 0.0% |
| Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | $68.5K | $77,083,000 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $68.4K | 7,752,487 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $67.1K | 6,554,967 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $55.2K | 2,907,784 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $45.5K | 4,865,647 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $37.9K | 4,452,445 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $37.3K | 1,262,382 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $35.4K | 895,422 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $25.7K | 3,199,559 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $24.5K | 4,055,876 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | $21.5K | 615,033 | 0.0% |
| Exelixis, Inc. Notes 4.25% 8/15/2019 | NOTE 4.25% 8/15/2019 | 30161QAC8 | $19.8K | $20,000,000 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $19.1K | 2,475,515 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $19.0K | 1,500,000 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $19.0K | 4,350,808 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $18.3K | 1,931,057 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | COM | 88322Q108 | $17.1K | 2,003,991 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | COM | 46116X101 | $16.9K | 609,166 | 0.0% |
| XenoPort, Inc. | COM | 98411C100 | $15.7K | 3,475,672 | 0.0% |